Is XTR or JNJ a better dividend investment in 2026?

XTR currently yields 18.99% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: XTR offers higher current income.

What is the dividend yield difference between XTR and JNJ?

XTR has a forward dividend yield of 18.99% ($4.71/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 15.63 percentage points.

Home › Compare › XTR vs JNJ

XTR vs JNJ: Dividend Comparison 2026

XTR yields 18.99% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XTR wins by $48.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XTR

● Live price

18.99%

Share price

$24.82

Annual div

$4.71

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$68.6K

Annual income

$6,044.13

Full XTR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — XTR vs JNJ

📍 XTR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XTR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XTR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XTR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XTR

Annual income on $10K today (after 15% tax)

$1,614.52/yr

After 10yr DRIP, annual income (after tax)

$5,137.51/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, XTR beats the other by $4,433.90/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XTR + JNJ for your $10,000?

XTR: 50%JNJ: 50%

100% JNJ50/50100% XTR

Portfolio after 10yr

$44.3K

Annual income

$3,435.95/yr

Blended yield

7.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XTR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XTR buys

JNJ buys

No recent congressional trades found for XTR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXTRJNJ

Forward yield	18.99% ✓	3.36%
Annual dividend / share	$4.71	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$68.6K ✓	$20.0K
Annual income after 10y	$6,044.13 ✓	$827.78
Total dividends collected	$38.0K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: XTR vs JNJ ($10,000, DRIP)

Year	XTR Portfolio	XTR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,599	$1,899.44	$10,676	$355.77	+$1.9K → XTR
2	$15,718	$2,236.62	$11,407	$389.39	+$4.3K → XTR
3	$19,426	$2,607.68	$12,198	$426.53	+$7.2K → XTR
4	$23,798	$3,012.01	$13,056	$467.62	+$10.7K → XTR
5	$28,912	$3,448.47	$13,987	$513.12	+$14.9K → XTR
6	$34,851	$3,915.48	$14,998	$563.56	+$19.9K → XTR
7	$41,702	$4,411.05	$16,098	$619.52	+$25.6K → XTR
8	$49,554	$4,932.83	$17,295	$681.69	+$32.3K → XTR
9	$58,501	$5,478.15	$18,599	$750.82	+$39.9K → XTR
10	$68,640	$6,044.13	$20,022	$827.78	+$48.6K → XTR

XTR vs JNJ: Complete Analysis 2026

XTR — Stock

The Global X S&P 500 Tail Risk ETF (XTR) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 Tail Risk Index.

Full XTR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this XTR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XTR vs SCHD XTR vs JEPI XTR vs O XTR vs KO XTR vs MAIN XTR vs ABBV XTR vs MRK XTR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.